Literature DB >> 6887149

Tyrosine supplementation during pregnancy in a woman with classical phenylketonuria. A case report.

R R Lenke, R Koch, K Fishler, L D Platt.   

Abstract

A woman with classical phenylketonuria (PKU) adhered poorly to a phenylalanine-restricted diet but did receive tyrosine supplementation from the 14th week of gestation until delivery. At birth the infant demonstrated a head circumference more than two standard deviations below the mean but at 2 years of age had a development quotient (DQ) of 94. This case illustrates the fact that while single case reports may be of value in disproving a theory, they are not sufficient to prove an association because biologic variation may explain one's results. Thus, while tyrosine supplementation may explain the relatively normal DQ, the results are also compatible with the moderate degree of phenylalanine restriction obtained. Current evidence favors the elevated maternal phenylalanine level as the cause of defects in offspring of women with PKU, but tyrosine supplementation should be considered if the level is subnormal.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6887149

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

Review 1.  Transport of amino acids by the human placenta: predicted effects thereon of maternal hyperphenylalaninaemia.

Authors:  Y Kudo; C A Boyd
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 2.  Phenylketonuria: tyrosine beyond the phenylalanine-restricted diet.

Authors:  F J van Spronsen; P G Smit; R Koch
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

3.  A psychosocial model of a medical problem: Maternal phenylketonuria.

Authors:  S Shiloh; S E Waisbren; H L Levy
Journal:  J Prim Prev       Date:  1989-09

Review 4.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.